Stony Brook, NY, February 06, 2014 – Applied DNA Sciences (OTCQB: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication, will host a circuit call on Tuesday February 11, 2014 to discuss its first quarter results. The Quarterly Report Form 10Q will be filed with the SEC by the position of the date on Monday February 10, 2014.
Applied DNA Sciences, Inc. management will host a conference call beginning at 9:00 a.m. eastern standard time on Tuesday February 11, 2014 to discuss the company’s performance and outline key ongoing and future business initiatives. A presentation by CEO and President Dr. James Hayward and CFO Karol Kain Gray will be followed by a question-and-answer session.
All participants obligation pre-register using the link below. It is suggested that you account into the conference call approximately 10 minutes prior to the scheduled start time to ensure that all participants are on-line at the start of the call. Period callers cannot be heard along the call, questions permitted be emailed beforehand to investor(at)adnas(dot)com.
For those of you cannot to participate, a transcript of the call legacy afsluiting posted by end of establishment on February 11, 2014, and available under the “Investors” tab of the company’s web site.
To Participate: Reserve your spot currently at: https://www3.gotomeeting.com/register/577039326
To Send Questions Prior to the Call: Please email questions preference to the yodle to investor(at)adnas(dot)com
Due to the large number of expected participants, not all questions permitted be answered on the call.
Company Background Materials: You may be interested in the company’s Investor Information section on the company’s web site, including publications, recent press releases, blogs, and other materials.
About Applied DNA Sciences APDN is a provider of botanical-DNA based security and authentication solutions that can relief protect products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNatureÂ® DNA plus DNANetÂ®, our principal anti-counterfeiting and product authentication solutions that essentially cannot be copied, render a forensic chain of evidence and can be used to prosecute perpetrators.
The statements made by APDN may indigen forward-looking in nature. Forward-looking statements describe APDN’s future plans, projections, strategies et sequens expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are further the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, peddle competition and sundry other factors detailed from time to time in APDN’s SEC reports and filings, including our Yearly Report on Form 10-K, filed on December 20, 2013 and our subsequent quarterly reports on Form 10-Q. APDN undertakes disagree obligation to renovate publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to deliberate the occurrence of unanticipated events.
media contiguous Mitchell Miller, 631-240-8818 investor contact Debbie Bailey, 631-240-8817 web adnas.com twitter @APDN, @APDNInvestor.
Applied DNA Sciences
Stony Brook, NY
+1 (631) 240-8818